RecruitingNot ApplicableNCT04779918

Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh

A Prospective Study Evaluating the Clinical Outcomes of Ventral or Inguinal Hernias Treated Robotically With OviTex® Reinforced Tissue Matrix

Sponsor

Tela Bio Inc

Enrollment

160 participants

Start Date

Apr 29, 2021

Study Type

INTERVENTIONAL

Conditions

Hernia, Inguinal Hernia, Ventral

Summary

This study is designed to evaluate the post-operative complications and hernia recurrence following the use of OviTex in subjects with ventral or inguinal hernias. Up to 160 subjects will participate in the study from up to 20 investigator sites.

Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called OviTex Reinforced Tissue Matrix for people with hernia, inguinal and hernia, ventral. The study is currently recruiting participants at 10 locations. People eligible for this study include aged 21 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEOviTex Reinforced Tissue Matrix

All study subjects will receive OviTex. All OviTex Reinforced Tissue Matrices are intended for use as a surgical mesh to reinforce or repair soft tissue where weakness exists.